Bringing new health technology to market it’s about trust, timing, market demand and clinical relevance.
With experience across Asia-Pacific, Avancely helps digital health and medtech organisations build evidence-led go-to-market strategies, shape demand, and design launch frameworks their teams can execute with confidence.
We work with founders and leadership teams to clarify markets, build strategic alignment, and create the frameworks that make successful execution possible.
Map the opportunity, audiences, and adoption barriers across target markets.
Design a provider-ready pilot framework to test value and evidence pathways.
Capture insights and proof points that inform procurement and messaging.
Translate validated learnings into a structured launch strategy and regional playbooks.
Launch strategies grounded in evidence and aligned with buyer expectations.
Faster internal alignment across commercial, clinical, and product teams.
Procurement-ready proof frameworks that shorten sales cycles.
Regional readiness plans tailored to Asia-Pacific market variation.
~ 4 - 6 weeks
Market scan, value proposition alignment, and provider-readiness audit to define launch direction.
Ideal for health tech teams preparing funding rounds or early market entry.
~ 6 - 12 weeks
Evidence design and KPI framework to prove value in real settings and support future tenders.
Used to clarify what proof is needed for scale and reimbursement.
Quarterly retainers
Ongoing support refining GTM plans, proof frameworks, and regional adaptation as markets evolve.
Designed for organisations preparing multiple market launches.
3 - 12 months
Interim senior expertise guiding GTM, pricing, and launch planning until permanent roles are in place.
Ideal for organisations building commercial capability.
It means your GTM strategy, pilot design, and messaging align with clinical, privacy, and procurement expectations so buyers can act with confidence.
Tight, 90-day pilots generate early clinical credibility and actionable data without long delays.
We help you adapt launch strategy and messaging for market realities across Asia-Pacific respecting different funding, policy, and care models.
Yes we can align technical, clinical, and commercial stories into one cohesive, evidence-based launch framework your team can deliver.
Yes. We offer fractional product or commercial strategy leadership to guide planning and capability building.
Avancely helps digital health and medtech teams turn innovation into credible launch strategies. We bring clarity, evidence, and regional insight so your team can execute with confidence.